drugset / Trial / NCT00049439
Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase 2
Completed
54 enrolled
Case Comprehensive Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining lomustine, etoposide, cyclophosphamide, and procarbazine in treating patients who have AIDS-related non-Hodgkin's lymphoma.
Timeline
- Start
- 1998-03
- Primary completion
- 2005-10
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | Oral |
| Subject | Etoposide | Small molecule | — | Oral |
| Subject | Lomustine | Small molecule | — | Oral |
| Subject | procarbazine | Small molecule | — | Oral |
| Background | filgrastim | Protein / enzyme biologic | — | Subcutaneous |